HOOVER R DAVID 4
4 · Elanco Animal Health Inc · Filed Dec 2, 2022
Insider Transaction Report
Form 4
HOOVER R DAVID
Director
Transactions
- Award
Common Stock
2022-11-30+18,649→ 57,916 total - Award
Deferred Stock Units
2022-11-30$12.87/sh+828.801$10,667→ 25,947.582 total→ Common Stock (828.801 underlying)
Holdings
- 15,920(indirect: By Trust)
Common Stock
- 145,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
- [F2]Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
- [F3]The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
- [F4]The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.